He received his MD from the University of Maryland School of Medicine and a Masters of Public Health at the Johns Hopkins Bloomberg School of Public Health. He completed his internal medicine and infectious diseases specialty training at UPMC. His current interests lie in HIV prevention with a focus on microbicides and oral pre-exposure prophylaxis, and he is the site principal investigator for a clinical trial looking at new types of pre-exposure prophylaxis being conducted through the HIV Prevention Trials Network and AIDS Clinical Trials Group. He is the medical director of the Pitt Mens Study, one of four sites comprising the Multicenter AIDS Cohort Study, and also serves as a pharmacovigilance safety officer with the NIH funded Microbicide Trials Network. He additionally provides clinical care at the Pittsburgh AIDS Center for Treatment and directs the Pre-exposure Prophylaxis (PrEP) clinic at UPMC.